NOVOZYMES A/S SPONS.ADR 1 Asset Resilience Ratio

Latest as of March 2026: 0.01%

NOVOZYMES A/S SPONS.ADR 1 asset resilience ratio. NOVOZYMES A/S SPONS.ADR 1 (NZM) has an Asset Resilience Ratio of 0.01% as of March 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read NZM total liabilities for a breakdown of total debt and financial obligations.

Liquid Assets

€2.20 Million
≈ $2.57 Million USD Cash + Short-term Investments

Total Assets

€16.52 Billion
≈ $19.32 Billion USD All company assets

Resilience Assessment

Low
Financial Resilience Level

Asset Resilience Ratio of NOVOZYMES A/S SPONS.ADR 1 (2021–2025)

Asset resilience ratio of NOVOZYMES A/S SPONS.ADR 1 from 2021 to 2025. This chart shows how NOVOZYMES A/S SPONS.ADR 1's Asset Resilience Ratio has changed over time. See NZM FCF generation index to measure how efficiently the company converts operating cash flow to free cash.

Liquid Assets Composition Over Time

This chart breaks down NOVOZYMES A/S SPONS.ADR 1's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see NOVOZYMES A/S SPONS.ADR 1 assets under control.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents €0.00 0%
Short-term Investments €2.20 Million 0.01%
Total Liquid Assets €2.20 Million 0.01%

Asset Resilience Insights

  • Limited Liquidity: NOVOZYMES A/S SPONS.ADR 1 maintains only 0.01% of assets in liquid form.
  • This low level may indicate efficient asset utilization but could pose risks during economic downturns.
  • The company has significant short-term investments, indicating active treasury management.

NOVOZYMES A/S SPONS.ADR 1 Industry Peers by Asset Resilience Ratio

Compare NOVOZYMES A/S SPONS.ADR 1's asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
International Flavors & Fragrances Inc
NYSE:IFF
Specialty Chemicals 2.31%
Akzo Nobel NV
AS:AKZA
Specialty Chemicals 2.16%
Incitec Pivot Ltd
AU:IPL
Specialty Chemicals 0.03%
Luxi Chemical Group Co Ltd
SHE:000830
Specialty Chemicals 0.43%
Tibet GaoZheng Explosive Co Ltd
SHE:002827
Specialty Chemicals 1.20%
Zibo Qixiang Tengda Chemical Co Ltd
SHE:002408
Specialty Chemicals 0.07%
Jilin OLED Material Tech Co Ltd
SHG:688378
Specialty Chemicals 9.22%
Chongqing Zaisheng Tech Corp
SHG:603601
Specialty Chemicals 13.69%

NOVOZYMES A/S SPONS.ADR 1 Asset Resilience Ratio by Year (2021–2025)

NOVOZYMES A/S SPONS.ADR 1 asset resilience ratio by year from 2021 to 2025. The table below shows the annual Asset Resilience Ratio data for NOVOZYMES A/S SPONS.ADR 1.

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
2025-12-31 0.12% €20.30 Million
≈ $23.73 Million
€16.35 Billion
≈ $19.11 Billion
+0.10pp
2024-12-31 0.03% €4.00 Million
≈ $4.68 Million
€15.20 Billion
≈ $17.77 Billion
-0.12pp
2023-12-31 0.14% €5.40 Million
≈ $6.31 Million
€3.81 Billion
≈ $4.45 Billion
-0.14pp
2022-12-31 0.29% €10.74 Million
≈ $12.55 Million
€3.76 Billion
≈ $4.39 Billion
-0.02pp
2021-12-31 0.30% €10.08 Million
≈ $11.79 Million
€3.33 Billion
≈ $3.89 Billion
--
pp = percentage points

About NOVOZYMES A/S SPONS.ADR 1

F:NZM Germany Specialty Chemicals
Market Cap
$24.08 Billion
€20.60 Billion EUR
Market Cap Rank
#1087 Global
#248 in Germany
Share Price
€50.00
Change (1 day)
+0.00%
52-Week Range
€44.80 - €66.00
All Time High
€67.43
About

Novozymes A/S produces and sells industrial enzymes, functional proteins, and microorganisms in Denmark, rest of Europe, North America, the Asia Pacific, the Middle East, Africa, Latin America, and internationally. The company provides biosolutions for the food and beverage industry, such as dairy, baking, beverage, meat, plant-based, functional, and other foods, as well as protein solutions and … Read more